Status:

COMPLETED

A Study of Modified Release Formulations of Danicopan in Healthy Adult Participants

Lead Sponsor:

Alexion Pharmaceuticals, Inc.

Collaborating Sponsors:

Achillion, a wholly owned subsidiary of Alexion

Conditions:

Healthy

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The purpose of this study was to evaluate and compare the plasma pharmacokinetic profiles of ACH-0144471 (danicopan) in healthy participants after administration of single oral doses of modified relea...

Eligibility Criteria

Inclusion

  • Body mass index of 18.0 to 30.0 kilograms/square meter.
  • Female participants of childbearing potential must either agree to abstinence or use of a highly effective method of contraception.
  • Male participants must either agree to abstinence or use of a condom plus an effective method of contraception.

Exclusion

  • Participants who have received any investigational medicinal product in a clinical research study within the previous 3 months.
  • History of any drug or alcohol abuse in the past 2 years; current tobacco/nicotine user or within the last 12 months; positive drugs of abuse test result.
  • Clinically significant laboratory abnormalities.
  • History of clinically significant cardiovascular, renal, hepatic, chronic respiratory or gastrointestinal disease, neurological or psychiatric disorder.
  • History or family history of meningococcal infection.
  • Serious adverse reaction or serious hypersensitivity to any drug or the formulation excipients.
  • Presence or history of clinically significant allergy requiring treatment.
  • Donation or loss of greater than 400 milliliters of blood within the previous 3 months.
  • Note: Other inclusion/exclusion criteria may apply, per protocol.

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 21 2018

Estimated Enrollment :

14 Patients enrolled

Trial Details

Trial ID

NCT03384186

Start Date

December 1 2017

End Date

March 21 2018

Last Update

August 20 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clinical Trial Site

Ruddington, Nottingham, United Kingdom, NG111 6JS